Goelzer Investment Management Inc. boosted its holdings in IQVIA (NYSE:IQV) by 34.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 68,513 shares of the medical research company’s stock after purchasing an additional 17,516 shares during the quarter. Goelzer Investment Management Inc.’s holdings in IQVIA were worth $6,722,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of IQV. Exxonmobil Investment Management Inc. TX acquired a new stake in IQVIA in the 4th quarter valued at $2,266,000. DnB Asset Management AS acquired a new stake in IQVIA in the 4th quarter valued at $8,813,000. First Citizens Bank & Trust Co. acquired a new stake in IQVIA in the 4th quarter valued at $1,067,000. Franklin Street Advisors Inc. NC acquired a new stake in IQVIA in the 4th quarter valued at $7,446,000. Finally, Nisa Investment Advisors LLC acquired a new stake in IQVIA in the 4th quarter valued at $920,000. 92.22% of the stock is owned by institutional investors and hedge funds.
Get IQVIA alerts:
In other news, insider James H. Erlinger III sold 10,000 shares of the business’s stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $100.00, for a total transaction of $1,000,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michael J. Evanisko sold 816 shares of the business’s stock in a transaction dated Monday, March 5th. The stock was sold at an average price of $100.00, for a total value of $81,600.00. The disclosure for this sale can be found here. Insiders have sold 12,527 shares of company stock valued at $1,257,834 in the last three months. 6.00% of the stock is owned by insiders.
IQV stock opened at $99.39 on Thursday. The company has a current ratio of 1.16, a quick ratio of 1.19 and a debt-to-equity ratio of 1.22. The firm has a market capitalization of $20.41 billion, a PE ratio of 20.30, a price-to-earnings-growth ratio of 1.66 and a beta of 0.64.
IQVIA (NYSE:IQV) last posted its earnings results on Wednesday, May 2nd. The medical research company reported $1.34 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.07. The business had revenue of $2.56 billion during the quarter, compared to analyst estimates of $2.42 billion. IQVIA had a return on equity of 13.35% and a net margin of 13.07%. The company’s revenue was up 34.1% compared to the same quarter last year. equities research analysts expect that IQVIA will post 5.06 earnings per share for the current fiscal year.
Several analysts recently issued reports on IQV shares. Zacks Investment Research raised shares of IQVIA from a “hold” rating to a “buy” rating and set a $112.00 price target for the company in a research report on Thursday, January 18th. Evercore ISI started coverage on shares of IQVIA in a report on Thursday, January 18th. They set an “outperform” rating and a $112.00 price objective on the stock. SunTrust Banks reaffirmed a “hold” rating and set a $110.00 price objective on shares of IQVIA in a report on Monday, January 22nd. Mizuho set a $97.00 price objective on shares of IQVIA and gave the stock a “hold” rating in a report on Wednesday, January 24th. Finally, JPMorgan Chase lifted their price objective on shares of IQVIA from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, February 15th. Seven analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. IQVIA presently has an average rating of “Buy” and an average target price of $110.47.
IQVIA Holdings Inc provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA (NYSE:IQV).